Detailed information for compound 1379369

Basic information

Technical information
  • TDR Targets ID: 1379369
  • Name: 2-[1-(2,2-dimethylpropyl)-3-oxopiperazin-2-yl ]-N-methyl-N-(1,2-oxazol-3-ylmethyl)acetamide
  • MW: 322.403 | Formula: C16H26N4O3
  • H donors: 1 H acceptors: 3 LogP: 0.55 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: CN(C(=O)CC1N(CCNC1=O)CC(C)(C)C)Cc1ccon1
  • InChi: 1S/C16H26N4O3/c1-16(2,3)11-20-7-6-17-15(22)13(20)9-14(21)19(4)10-12-5-8-23-18-12/h5,8,13H,6-7,9-11H2,1-4H3,(H,17,22)
  • InChiKey: MLQNAOVBWCCFGU-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[1-(2,2-dimethylpropyl)-3-oxo-piperazin-2-yl]-N-(isoxazol-3-ylmethyl)-N-methyl-acetamide
  • 2-[1-(2,2-dimethylpropyl)-3-oxo-2-piperazinyl]-N-(3-isoxazolylmethyl)-N-methylacetamide
  • N-(isoxazol-3-ylmethyl)-2-(3-keto-1-neopentyl-piperazin-2-yl)-N-methyl-acetamide
  • 2-[1-(2,2-dimethylpropyl)-3-oxo-piperazin-2-yl]-N-methyl-N-(1,2-oxazol-3-ylmethyl)ethanamide
  • 2-[1-(2,2-dimethylpropyl)-3-oxopiperazin-2-yl]-N-(isoxazol-3-ylmethyl)-N-methylacetamide
  • MLS000773225
  • SMR000317949

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens ataxin 2 Starlite/ChEMBL No references
Giardia intestinalis Putative fructose-1,6-bisphosphate aldolase Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Trichomonas vaginalis fructose-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Trichomonas vaginalis fructose-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Trichomonas vaginalis fructose-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Trichomonas vaginalis fructose-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Treponema pallidum fructose-bisphosphate aldolase Get druggable targets OG5_129214 All targets in OG5_129214
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Trichomonas vaginalis fructose-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Trichomonas vaginalis fructose-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Trichomonas vaginalis fructose-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Trichomonas vaginalis fructose-bisphosphate aldolase, putative Get druggable targets OG5_129214 All targets in OG5_129214
Giardia lamblia Fructose-bisphosphate aldolase Get druggable targets OG5_129214 All targets in OG5_129214

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium ulcerans fructose-bisphosphate aldolase Putative fructose-1,6-bisphosphate aldolase   323 aa 361 aa 26.9 %
Mycobacterium leprae Probable fructose bisphosphate aldolase Fba Putative fructose-1,6-bisphosphate aldolase   323 aa 361 aa 25.8 %
Mycobacterium tuberculosis Probable fructose-bisphosphate aldolase Fba Putative fructose-1,6-bisphosphate aldolase   323 aa 361 aa 25.5 %
Candida albicans fructose-bisphosphate aldolase Putative fructose-1,6-bisphosphate aldolase   323 aa 358 aa 22.6 %
Candida albicans fructose-bisphosphate aldolase Putative fructose-1,6-bisphosphate aldolase   323 aa 358 aa 22.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica fructose-1,6-bisphosphate aldolase, putative 0.0353 1 1
Schistosoma mansoni tar DNA-binding protein 0.0135 0.3071 1
Toxoplasma gondii aldehyde dehydrogenase 0.0065 0.0845 0.5
Echinococcus multilocularis tar DNA binding protein 0.0135 0.3071 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0353 1 0.5
Schistosoma mansoni tar DNA-binding protein 0.0135 0.3071 1
Leishmania major aldehyde dehydrogenase, mitochondrial precursor 0.0065 0.0845 0.5
Schistosoma mansoni tar DNA-binding protein 0.0135 0.3071 1
Mycobacterium leprae Probable fructose bisphosphate aldolase Fba 0.0172 0.4257 0.5
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0353 1 0.5
Brugia malayi RNA recognition motif domain containing protein 0.0135 0.3071 1
Schistosoma mansoni aldehyde dehydrogenase 0.0065 0.0845 0.2751
Mycobacterium tuberculosis Probable fructose-bisphosphate aldolase Fba 0.0172 0.4257 1
Schistosoma mansoni tar DNA-binding protein 0.0135 0.3071 1
Mycobacterium ulcerans fructose-bisphosphate aldolase 0.0172 0.4257 1
Echinococcus granulosus aldehyde dehydrogenase mitochondrial 0.0065 0.0845 0.2751
Schistosoma mansoni tar DNA-binding protein 0.0135 0.3071 1
Loa Loa (eye worm) RNA recognition domain-containing protein domain-containing protein 0.0135 0.3071 0.5
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0353 1 0.5
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0353 1 0.5
Loa Loa (eye worm) RNA binding protein 0.0135 0.3071 0.5
Schistosoma mansoni aldehyde dehydrogenase 0.0065 0.0845 0.2751
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0353 1 0.5
Loa Loa (eye worm) TAR-binding protein 0.0135 0.3071 0.5
Brugia malayi TAR-binding protein 0.0135 0.3071 1
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0353 1 0.5
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0353 1 0.5
Brugia malayi RNA binding protein 0.0135 0.3071 1
Treponema pallidum fructose-bisphosphate aldolase 0.0353 1 0.5
Trichomonas vaginalis fructose-bisphosphate aldolase, putative 0.0353 1 0.5
Echinococcus granulosus tar DNA binding protein 0.0135 0.3071 1
Giardia lamblia Fructose-bisphosphate aldolase 0.0353 1 0.5
Echinococcus multilocularis aldehyde dehydrogenase, mitochondrial 0.0065 0.0845 0.2751

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 5.0119 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 14.0919 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ] ChEMBL. No reference
Potency (functional) = 28.1838 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 44.6684 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.